FDA granted approval to Zepzelca in 2025, which was approved in partnership with Roche's Tecentriq.

The entities involved

• Jazz Pharmaceuticals →

  Irish tax-registered pharmaceutical corporation

  • Jazz Pharmaceuticals plans U.S. launch of Ziihera.Wed 22:28
  • Alan M. Sebulsky was appointed to the Board of Directors of MeiraGTx Holdings PLC, where he has previously served.Wed 13:55
• Food and Drug Administration →

  government organization in Nonthaburi, Thailand

  • Trump is expected to nominate Heidi Overton to lead the Food and Drug Administration.Mon 15:49
  • In 2007, CBS broadcast featured Andrews, Cordes, and Couric criticizing the Food and Drug Administration's problems.Mon 12:46
• Hoffmann-La Roche →

  Swiss healthcare company

  • Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
  • Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08

Related events

• The FDA has delayed potential approval of a cancer treatment that utilizes Exelixis in combination with Roche's Tecentriq.Sep 11
• The FDA approved various advanced therapies, including oral medication from Roche, a gene-targeting drug from Biogen, and a one-time gene therapy from Novartis.Sep 14